-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Aprea Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2024.
- Aprea Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$3.23M, a 12.2% increase year-over-year.
- Aprea Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$14.3M, a 7.45% increase year-over-year.
- Aprea Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$14.3M, a 7.45% increase from 2023.
- Aprea Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$15.5M, a 86.4% increase from 2022.
- Aprea Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$113M, a 203% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)